BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21521888)

  • 1. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?
    Parham K
    Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW; Morest DK; Parham K
    Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
    Hughes AL; Hussain N; Pafford R; Parham K
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
    Daldal A; Odabasi O; Serbetcioglu B
    Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats.
    Paksoy M; Ayduran E; Sanlı A; Eken M; Aydın S; Oktay ZA
    Med Oncol; 2011 Jun; 28(2):615-21. PubMed ID: 20300971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
    Miller MW; Riedel G; Hoistad D; Sutherland C; Juhn SK; Adams GL; Griffin R; Ondrey FG
    Am J Otolaryngol; 2009; 30(1):1-7. PubMed ID: 19027506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model.
    Kavanagh KR; Parham K; Schoem SR
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):238-41. PubMed ID: 19289700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxic protection of sodium thiosulfate: daily vs constant infusion.
    Stocks RM; Gould HJ; Bush AJ; Dudney BW; Pousson M; Thompson JW
    Otolaryngol Head Neck Surg; 2004 Jul; 131(1):115-9. PubMed ID: 15243567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity.
    Özel HE; Özdoğan F; Gürgen SG; Esen E; Genç S; Selçuk A
    J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
    Fernandez R; Harrop-Jones A; Wang X; Dellamary L; LeBel C; Piu F
    Audiol Neurootol; 2016; 21(1):22-9. PubMed ID: 26789647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
    Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
    Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Ototoxicity across Species.
    Blakley BW; Hochman J; Wellman M; Gooi A; Hussain AE
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):700-3. PubMed ID: 19128679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.